Key Statistics
Market Cap$51.26M
P/E RatioN/A
Div. Yield—
EPS (TTM)-$1.07
52W High$9.37
52W Low$0.72
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
Employees17
Price Performance
1 Week+15.20%
3 Month+314.78%
1 Year+165.80%
FinancialsAnnual · QuiverQuant
Revenue—
Assets$8.89M
Liabilities$1.84M
Net Income$8.37M
About
Edesa Biotech, Inc., a clinical-stage biopharmaceutical company, is engaged in the research and development, manufacture and marketing of pharmaceuticals for inflammatory and immune-related diseases. The company is headquartered in Markham, Canada.
WebullFree stocks
Advanced charting, extended hours trading, and free stock for new accounts.
Analyze EDSA with professional charts— Free to start
Price data sourced from Polygon.io (previous trading day close). Fundamentals from Alpha Vantage. Insider trades from SEC EDGAR. Cached via Cloudflare KV.